Physician profile
William B Smith
NPI 1003010299
$3,915.30
in general payments reported to CMS, 2019-2025
8 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,585 · 2020: $385 · 2021: $340 · 2022: $91.73 · 2023: $32.00 · 2024: $1,340 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $975 · Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $975.33 |
| Food and Beverage | $538.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,587.30 | 2019-2024 | Amplatzer Amulet |
| Edwards Lifesciences Corporation | $525.32 | 2019-2025 | Sapien 3 Ultra Resilia, Hemosphere |
| Medtronic Vascular, INC. | $402.85 | 2019-2020 | |
| Abiomed | $131.57 | 2021 | |
| Boston Scientific Corporation | $121.63 | 2024 | Watchman Flx |
| Pacira Pharmaceuticals Incorporated | $82.87 | 2025 | Exparel |
| Medtronic, INC. | $46.19 | 2021-2023 | Apollotm |
| Biosense Webster, INC. | $17.57 | 2024 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.